StockData

Beyond Meat vs Medifast

BYND and MED side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BYND and MED compare

Beyond Meat is the larger company, worth 18 times as much as Medifast ($2.4B against $136M).

Beyond Meat grew revenue faster over the last twelve months (−14.1% versus −30.3% for Medifast).

Beyond Meat keeps more of each dollar of sales as profit, with a net margin of 112% compared with −13.6% at Medifast.

Medifast scores higher on the StockData Score (10 against 3 for Beyond Meat), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBYNDMED
Size and price
Market cap$2.4B$136M
Share price$4.70$12.19
Change, 1 year−85.5%7.1%
Change, 5 years−99.8%−94.2%
Beta (5Y)2.211.53
Employees589380
StockData Score
Total score310 (better)
Valuation score03 (better)
Growth score01 (better)
Performance score2 (better)0
Health score16 (better)
Dividend score00
Valuation
P/S9.4×0.5× (better)
P/B42.7×0.8× (better)
FCF yield−5.0%−2.8% (better)
Fair value–$28.62
Margin of safety–57.4%
Growth
Revenue growth (TTM)−14.1% (better)−30.3%
Revenue growth, 5Y average−7.5% (better)−16.2%
Net income growth (TTM)–−16573%
EPS growth (TTM)–−37000%
Profitability
Gross margin3.1%69.2% (better)
Operating margin−121%−11.6% (better)
Net margin112% (better)−13.6%
FCF margin−46.4%−1.3% (better)
Return on equity–−20.7%
Return on invested capital−103% (better)−110%
Financial health
Debt / equity5.70 (better)0.00
Interest coverage−12.9×–
Current ratio2.634.82 (better)
Altman Z-score−0.693.74 (better)
Piotroski F-score34 (better)
Dividends and buybacks
Dividend yield–0.00%
Years of dividend growth–0
Shareholder yield0.00%0.00%
Ownership
Held by institutions0.78%73.9%
Held by insiders8.8%12.3%
Insider net buying, 12 months−$282K$1.5M (better)
Superinvestors holding1–
Short interest, % of float1.3%13.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.